{"transactions":[{"id":746138,"issuer":{"id":4463,"kind":"organization","name":"Aurinia Pharmaceuticals Inc.","symbol":"AUPH"},"owners":[{"id":40463,"kind":"person","name":"Bailey Jeffrey Allen","position":1,"cik":"0001500210","reported_name":"Bailey Jeffrey Allen","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Director Stock Option (right to buy)","published_at":"2026-06-08T20:08:50.000Z","date":"2026-06-04","kind":"grant","planned":false,"acquired":true,"shares":23931,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options shall vest one year from date of grant."}],"balance_after":23931,"derivative":{"exercise_price":15.67,"expiration_date":"2036-06-04","underlying":"Common Shares","underlying_shares":23931},"source":{"system":"sec-edgar","filing":"0001500210-26-000002","document":"wk-form4_1780949328.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1500210/000150021026000002/wk-form4_1780949328.xml","form_type":"4"}},{"id":989957,"issuer":{"id":4463,"kind":"organization","name":"Aurinia Pharmaceuticals Inc.","symbol":"AUPH"},"owners":[{"id":40463,"kind":"person","name":"Bailey Jeffrey Allen","position":1,"cik":"0001500210","reported_name":"Bailey Jeffrey Allen","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Shares","published_at":"2025-11-24T22:19:15.000Z","date":"2025-11-21","kind":"tax_withholding","planned":false,"acquired":false,"shares":2716,"price":15.68,"value":42586.88,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares withheld to satisfy tax withholding obligations upon the vesting of restricted stock units."}],"balance_after":22775,"source":{"system":"sec-edgar","filing":"0001600620-25-000110","document":"wk-form4_1764022752.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1500210/000160062025000110/wk-form4_1764022752.xml","form_type":"4"}},{"id":1145342,"issuer":{"id":4463,"kind":"organization","name":"Aurinia Pharmaceuticals Inc.","symbol":"AUPH"},"owners":[{"id":40463,"kind":"person","name":"Bailey Jeffrey Allen","position":1,"cik":"0001500210","reported_name":"Bailey Jeffrey Allen","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Director Stock Option (right to buy)","published_at":"2025-05-16T21:04:19.000Z","date":"2025-05-16","kind":"grant","planned":false,"acquired":true,"shares":37485,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options shall vest one year from date of grant."}],"balance_after":37485,"derivative":{"exercise_price":8.15,"expiration_date":"2035-05-16","underlying":"Common Shares","underlying_shares":37485},"source":{"system":"sec-edgar","filing":"0001600620-25-000075","document":"wk-form4_1747429452.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1500210/000160062025000075/wk-form4_1747429452.xml","form_type":"4"}},{"id":1352651,"issuer":{"id":4463,"kind":"organization","name":"Aurinia Pharmaceuticals Inc.","symbol":"AUPH"},"owners":[{"id":40463,"kind":"person","name":"Bailey Jeffrey Allen","position":1,"cik":"0001500210","reported_name":"Bailey Jeffrey Allen","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Director Stock Option (right to buy)","published_at":"2024-11-25T21:30:53.000Z","date":"2024-11-21","kind":"grant","planned":false,"acquired":true,"shares":18641,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The options shall vest one year from date of grant."}],"balance_after":18641,"derivative":{"exercise_price":8.24,"expiration_date":"2034-11-21","underlying":"Common Shares","underlying_shares":18641},"source":{"system":"sec-edgar","filing":"0001600620-24-000120","document":"wk-form4_1732570246.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1500210/000160062024000120/wk-form4_1732570246.xml","form_type":"4"}},{"id":1352650,"issuer":{"id":4463,"kind":"organization","name":"Aurinia Pharmaceuticals Inc.","symbol":"AUPH"},"owners":[{"id":40463,"kind":"person","name":"Bailey Jeffrey Allen","position":1,"cik":"0001500210","reported_name":"Bailey Jeffrey Allen","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Shares","published_at":"2024-11-25T21:30:53.000Z","date":"2024-11-21","kind":"grant","planned":false,"acquired":true,"shares":12135,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents grant of Restricted Stock Units (RSUs) payable solely in common shares of the Issuer. The shares subject to the RSUs shall vest one year from date of grant."}],"balance_after":25491,"source":{"system":"sec-edgar","filing":"0001600620-24-000120","document":"wk-form4_1732570246.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1500210/000160062024000120/wk-form4_1732570246.xml","form_type":"4"}},{"id":1368840,"issuer":{"id":4463,"kind":"organization","name":"Aurinia Pharmaceuticals Inc.","symbol":"AUPH"},"owners":[{"id":40463,"kind":"person","name":"Bailey Jeffrey Allen","position":1,"cik":"0001500210","reported_name":"Bailey Jeffrey Allen","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2024-11-13T00:29:43.000Z","date":"2024-11-08","kind":"exercise","planned":false,"acquired":false,"shares":17913,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each Restricted Stock Unit (\"RSU\") represents a contingent right to receive one share of the Issuer's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The RSUs vested one year from date of grant and have no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"The RSUs vested one year from date of grant and have no expiration date."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":17913},"source":{"system":"sec-edgar","filing":"0001600620-24-000116","document":"wk-form4_1731457775.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1500210/000160062024000116/wk-form4_1731457775.xml","form_type":"4"}},{"id":1368839,"issuer":{"id":4463,"kind":"organization","name":"Aurinia Pharmaceuticals Inc.","symbol":"AUPH"},"owners":[{"id":40463,"kind":"person","name":"Bailey Jeffrey Allen","position":1,"cik":"0001500210","reported_name":"Bailey Jeffrey Allen","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-11-13T00:29:43.000Z","date":"2024-11-11","kind":"sale","planned":false,"acquired":false,"shares":4557,"price":8.43,"value":38415.51,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Represents the number of shares automatically sold to cover tax withholding obligations in connection with the vesting of RSUs."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price in column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $8.37 to $8.47, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range."}],"balance_after":13356,"source":{"system":"sec-edgar","filing":"0001600620-24-000116","document":"wk-form4_1731457775.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1500210/000160062024000116/wk-form4_1731457775.xml","form_type":"4"}},{"id":1368838,"issuer":{"id":4463,"kind":"organization","name":"Aurinia Pharmaceuticals Inc.","symbol":"AUPH"},"owners":[{"id":40463,"kind":"person","name":"Bailey Jeffrey Allen","position":1,"cik":"0001500210","reported_name":"Bailey Jeffrey Allen","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-11-13T00:29:43.000Z","date":"2024-11-08","kind":"exercise","planned":false,"acquired":true,"shares":17913,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each Restricted Stock Unit (\"RSU\") represents a contingent right to receive one share of the Issuer's common stock."}],"balance_after":17913,"source":{"system":"sec-edgar","filing":"0001600620-24-000116","document":"wk-form4_1731457775.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1500210/000160062024000116/wk-form4_1731457775.xml","form_type":"4"}},{"id":1800724,"issuer":{"id":4463,"kind":"organization","name":"Aurinia Pharmaceuticals Inc.","symbol":"AUPH"},"owners":[{"id":40463,"kind":"person","name":"Bailey Jeffrey Allen","position":1,"cik":"0001500210","reported_name":"Bailey Jeffrey Allen","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2023-08-21T20:25:12.000Z","date":"2023-08-18","kind":"grant","planned":false,"acquired":true,"shares":28959,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option vests in twelve equal monthly installments commencing on September 18, 2023."}],"balance_after":28959,"derivative":{"exercise_price":9.49,"expiration_date":"2033-08-18","underlying":"Common Stock","underlying_shares":28959},"source":{"system":"sec-edgar","filing":"0001600620-23-000038","document":"wk-form4_1692649498.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1500210/000160062023000038/wk-form4_1692649498.xml","form_type":"4"}},{"id":1800723,"issuer":{"id":4463,"kind":"organization","name":"Aurinia Pharmaceuticals Inc.","symbol":"AUPH"},"owners":[{"id":40463,"kind":"person","name":"Bailey Jeffrey Allen","position":1,"cik":"0001500210","reported_name":"Bailey Jeffrey Allen","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2023-08-21T20:25:12.000Z","date":"2023-08-18","kind":"grant","planned":false,"acquired":true,"shares":17913,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each Restricted Stock Unit (\"RSU\") represents a contingent right to receive one share of the Issuer's common stock. The RSUs will vest one year from date of grant and have no expiration date. Vested shares will be delivered on August 18, 2024."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each Restricted Stock Unit (\"RSU\") represents a contingent right to receive one share of the Issuer's common stock. The RSUs will vest one year from date of grant and have no expiration date. Vested shares will be delivered on August 18, 2024."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each Restricted Stock Unit (\"RSU\") represents a contingent right to receive one share of the Issuer's common stock. The RSUs will vest one year from date of grant and have no expiration date. Vested shares will be delivered on August 18, 2024."}],"balance_after":17913,"derivative":{"underlying":"Common Stock","underlying_shares":17913},"source":{"system":"sec-edgar","filing":"0001600620-23-000038","document":"wk-form4_1692649498.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1500210/000160062023000038/wk-form4_1692649498.xml","form_type":"4"}},{"id":2227762,"issuer":{"id":7071,"kind":"organization","name":"Rein Therapeutics, Inc."},"owners":[{"id":40463,"kind":"person","name":"Bailey Jeffrey Allen","position":1,"cik":"0001500210","reported_name":"Bailey Jeffrey Allen","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2022-06-17T21:10:49.000Z","date":"2022-06-15","kind":"grant","acquired":true,"shares":54500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option was granted on June 15, 2022. The shares underlying the option are scheduled to vest in full on the earlier of (i) June 15, 2023 or (ii) the date of the Issuer's 2023 Annual Meeting of Stockholders."}],"balance_after":54500,"derivative":{"exercise_price":0.397,"expiration_date":"2032-06-14","underlying":"Common Stock","underlying_shares":54500},"source":{"system":"sec-edgar","filing":"0000899243-22-023133","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1500210/000089924322023133/doc4.xml","form_type":"4"}},{"id":2321920,"issuer":{"id":128876,"kind":"organization","name":"BIODELIVERY SCIENCES INTERNATIONAL INC","symbol":"BDSI"},"owners":[{"id":40463,"kind":"person","name":"Bailey Jeffrey Allen","position":1,"cik":"0001500210","reported_name":"Bailey Jeffrey Allen","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Options (right to buy)","published_at":"2022-03-22T17:11:07.000Z","date":"2022-03-22","kind":"disposition_to_issuer","acquired":false,"shares":1143467,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Immediately prior to the Effective Time, each Issuer option that was outstanding and then exercisable for a per share exercise price less than the Merger Consideration that would be payable in respect of the Shares underlying such Issuer option (any such Issuer option, an \"In-the-Money Cash Out Option\") was cancelled and automatically converted into the right to receive for each Share underlying such Issuer option, without interest and subject to deduction for any required withholding taxes, an amount in cash equal to the excess of the Merger Consideration over the per share exercise price of such In-the-Money Cash Out Option. All Issuer options that were not In-the-Money Cash Out Options were cancelled at the Effective Time without payment of any consideration."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Immediately prior to the Effective Time, each Issuer option that was outstanding and then exercisable for a per share exercise price less than the Merger Consideration that would be payable in respect of the Shares underlying such Issuer option (any such Issuer option, an \"In-the-Money Cash Out Option\") was cancelled and automatically converted into the right to receive for each Share underlying such Issuer option, without interest and subject to deduction for any required withholding taxes, an amount in cash equal to the excess of the Merger Consideration over the per share exercise price of such In-the-Money Cash Out Option. All Issuer options that were not In-the-Money Cash Out Options were cancelled at the Effective Time without payment of any consideration."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"Immediately prior to the Effective Time, each Issuer option that was outstanding and then exercisable for a per share exercise price less than the Merger Consideration that would be payable in respect of the Shares underlying such Issuer option (any such Issuer option, an \"In-the-Money Cash Out Option\") was cancelled and automatically converted into the right to receive for each Share underlying such Issuer option, without interest and subject to deduction for any required withholding taxes, an amount in cash equal to the excess of the Merger Consideration over the per share exercise price of such In-the-Money Cash Out Option. All Issuer options that were not In-the-Money Cash Out Options were cancelled at the Effective Time without payment of any consideration."}],"balance_after":0,"derivative":{"exercise_price":3.66,"underlying":"Common Stock","underlying_shares":1143467},"source":{"system":"sec-edgar","filing":"0001103021-22-000065","document":"wf-form4_164798344795443.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1103021/000110302122000065/wf-form4_164798344795443.xml","form_type":"4"}},{"id":2321919,"issuer":{"id":128876,"kind":"organization","name":"BIODELIVERY SCIENCES INTERNATIONAL INC","symbol":"BDSI"},"owners":[{"id":40463,"kind":"person","name":"Bailey Jeffrey Allen","position":1,"cik":"0001500210","reported_name":"Bailey Jeffrey Allen","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Options (right to buy)","published_at":"2022-03-22T17:11:07.000Z","date":"2022-03-22","kind":"disposition_to_issuer","acquired":false,"shares":840000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Immediately prior to the Effective Time, each Issuer option that was outstanding and then exercisable for a per share exercise price less than the Merger Consideration that would be payable in respect of the Shares underlying such Issuer option (any such Issuer option, an \"In-the-Money Cash Out Option\") was cancelled and automatically converted into the right to receive for each Share underlying such Issuer option, without interest and subject to deduction for any required withholding taxes, an amount in cash equal to the excess of the Merger Consideration over the per share exercise price of such In-the-Money Cash Out Option. All Issuer options that were not In-the-Money Cash Out Options were cancelled at the Effective Time without payment of any consideration."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Immediately prior to the Effective Time, each Issuer option that was outstanding and then exercisable for a per share exercise price less than the Merger Consideration that would be payable in respect of the Shares underlying such Issuer option (any such Issuer option, an \"In-the-Money Cash Out Option\") was cancelled and automatically converted into the right to receive for each Share underlying such Issuer option, without interest and subject to deduction for any required withholding taxes, an amount in cash equal to the excess of the Merger Consideration over the per share exercise price of such In-the-Money Cash Out Option. All Issuer options that were not In-the-Money Cash Out Options were cancelled at the Effective Time without payment of any consideration."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"Immediately prior to the Effective Time, each Issuer option that was outstanding and then exercisable for a per share exercise price less than the Merger Consideration that would be payable in respect of the Shares underlying such Issuer option (any such Issuer option, an \"In-the-Money Cash Out Option\") was cancelled and automatically converted into the right to receive for each Share underlying such Issuer option, without interest and subject to deduction for any required withholding taxes, an amount in cash equal to the excess of the Merger Consideration over the per share exercise price of such In-the-Money Cash Out Option. All Issuer options that were not In-the-Money Cash Out Options were cancelled at the Effective Time without payment of any consideration."}],"balance_after":0,"derivative":{"exercise_price":3.6,"underlying":"Common Stock","underlying_shares":840000},"source":{"system":"sec-edgar","filing":"0001103021-22-000065","document":"wf-form4_164798344795443.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1103021/000110302122000065/wf-form4_164798344795443.xml","form_type":"4"}},{"id":2321918,"issuer":{"id":128876,"kind":"organization","name":"BIODELIVERY SCIENCES INTERNATIONAL INC","symbol":"BDSI"},"owners":[{"id":40463,"kind":"person","name":"Bailey Jeffrey Allen","position":1,"cik":"0001500210","reported_name":"Bailey Jeffrey Allen","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Options (right to buy)","published_at":"2022-03-22T17:11:07.000Z","date":"2022-03-22","kind":"disposition_to_issuer","acquired":false,"shares":66805,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Immediately prior to the Effective Time, each Issuer option that was outstanding and then exercisable for a per share exercise price less than the Merger Consideration that would be payable in respect of the Shares underlying such Issuer option (any such Issuer option, an \"In-the-Money Cash Out Option\") was cancelled and automatically converted into the right to receive for each Share underlying such Issuer option, without interest and subject to deduction for any required withholding taxes, an amount in cash equal to the excess of the Merger Consideration over the per share exercise price of such In-the-Money Cash Out Option. All Issuer options that were not In-the-Money Cash Out Options were cancelled at the Effective Time without payment of any consideration."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Immediately prior to the Effective Time, each Issuer option that was outstanding and then exercisable for a per share exercise price less than the Merger Consideration that would be payable in respect of the Shares underlying such Issuer option (any such Issuer option, an \"In-the-Money Cash Out Option\") was cancelled and automatically converted into the right to receive for each Share underlying such Issuer option, without interest and subject to deduction for any required withholding taxes, an amount in cash equal to the excess of the Merger Consideration over the per share exercise price of such In-the-Money Cash Out Option. All Issuer options that were not In-the-Money Cash Out Options were cancelled at the Effective Time without payment of any consideration."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"Immediately prior to the Effective Time, each Issuer option that was outstanding and then exercisable for a per share exercise price less than the Merger Consideration that would be payable in respect of the Shares underlying such Issuer option (any such Issuer option, an \"In-the-Money Cash Out Option\") was cancelled and automatically converted into the right to receive for each Share underlying such Issuer option, without interest and subject to deduction for any required withholding taxes, an amount in cash equal to the excess of the Merger Consideration over the per share exercise price of such In-the-Money Cash Out Option. All Issuer options that were not In-the-Money Cash Out Options were cancelled at the Effective Time without payment of any consideration."}],"balance_after":0,"derivative":{"exercise_price":4.36,"underlying":"Common Stock","underlying_shares":66805},"source":{"system":"sec-edgar","filing":"0001103021-22-000065","document":"wf-form4_164798344795443.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1103021/000110302122000065/wf-form4_164798344795443.xml","form_type":"4"}},{"id":2321917,"issuer":{"id":128876,"kind":"organization","name":"BIODELIVERY SCIENCES INTERNATIONAL INC","symbol":"BDSI"},"owners":[{"id":40463,"kind":"person","name":"Bailey Jeffrey Allen","position":1,"cik":"0001500210","reported_name":"Bailey Jeffrey Allen","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Options (right to buy)","published_at":"2022-03-22T17:11:07.000Z","date":"2022-03-22","kind":"disposition_to_issuer","acquired":false,"shares":160000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Immediately prior to the Effective Time, each Issuer option that was outstanding and then exercisable for a per share exercise price less than the Merger Consideration that would be payable in respect of the Shares underlying such Issuer option (any such Issuer option, an \"In-the-Money Cash Out Option\") was cancelled and automatically converted into the right to receive for each Share underlying such Issuer option, without interest and subject to deduction for any required withholding taxes, an amount in cash equal to the excess of the Merger Consideration over the per share exercise price of such In-the-Money Cash Out Option. All Issuer options that were not In-the-Money Cash Out Options were cancelled at the Effective Time without payment of any consideration."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Immediately prior to the Effective Time, each Issuer option that was outstanding and then exercisable for a per share exercise price less than the Merger Consideration that would be payable in respect of the Shares underlying such Issuer option (any such Issuer option, an \"In-the-Money Cash Out Option\") was cancelled and automatically converted into the right to receive for each Share underlying such Issuer option, without interest and subject to deduction for any required withholding taxes, an amount in cash equal to the excess of the Merger Consideration over the per share exercise price of such In-the-Money Cash Out Option. All Issuer options that were not In-the-Money Cash Out Options were cancelled at the Effective Time without payment of any consideration."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"Immediately prior to the Effective Time, each Issuer option that was outstanding and then exercisable for a per share exercise price less than the Merger Consideration that would be payable in respect of the Shares underlying such Issuer option (any such Issuer option, an \"In-the-Money Cash Out Option\") was cancelled and automatically converted into the right to receive for each Share underlying such Issuer option, without interest and subject to deduction for any required withholding taxes, an amount in cash equal to the excess of the Merger Consideration over the per share exercise price of such In-the-Money Cash Out Option. All Issuer options that were not In-the-Money Cash Out Options were cancelled at the Effective Time without payment of any consideration."}],"balance_after":0,"derivative":{"exercise_price":4.23,"underlying":"Common Stock","underlying_shares":160000},"source":{"system":"sec-edgar","filing":"0001103021-22-000065","document":"wf-form4_164798344795443.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1103021/000110302122000065/wf-form4_164798344795443.xml","form_type":"4"}},{"id":2321916,"issuer":{"id":128876,"kind":"organization","name":"BIODELIVERY SCIENCES INTERNATIONAL INC","symbol":"BDSI"},"owners":[{"id":40463,"kind":"person","name":"Bailey Jeffrey Allen","position":1,"cik":"0001500210","reported_name":"Bailey Jeffrey Allen","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Options (right to buy)","published_at":"2022-03-22T17:11:07.000Z","date":"2022-03-22","kind":"disposition_to_issuer","acquired":false,"shares":96000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Immediately prior to the Effective Time, each Issuer option that was outstanding and then exercisable for a per share exercise price less than the Merger Consideration that would be payable in respect of the Shares underlying such Issuer option (any such Issuer option, an \"In-the-Money Cash Out Option\") was cancelled and automatically converted into the right to receive for each Share underlying such Issuer option, without interest and subject to deduction for any required withholding taxes, an amount in cash equal to the excess of the Merger Consideration over the per share exercise price of such In-the-Money Cash Out Option. All Issuer options that were not In-the-Money Cash Out Options were cancelled at the Effective Time without payment of any consideration."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Immediately prior to the Effective Time, each Issuer option that was outstanding and then exercisable for a per share exercise price less than the Merger Consideration that would be payable in respect of the Shares underlying such Issuer option (any such Issuer option, an \"In-the-Money Cash Out Option\") was cancelled and automatically converted into the right to receive for each Share underlying such Issuer option, without interest and subject to deduction for any required withholding taxes, an amount in cash equal to the excess of the Merger Consideration over the per share exercise price of such In-the-Money Cash Out Option. All Issuer options that were not In-the-Money Cash Out Options were cancelled at the Effective Time without payment of any consideration."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"Immediately prior to the Effective Time, each Issuer option that was outstanding and then exercisable for a per share exercise price less than the Merger Consideration that would be payable in respect of the Shares underlying such Issuer option (any such Issuer option, an \"In-the-Money Cash Out Option\") was cancelled and automatically converted into the right to receive for each Share underlying such Issuer option, without interest and subject to deduction for any required withholding taxes, an amount in cash equal to the excess of the Merger Consideration over the per share exercise price of such In-the-Money Cash Out Option. All Issuer options that were not In-the-Money Cash Out Options were cancelled at the Effective Time without payment of any consideration."}],"balance_after":0,"derivative":{"exercise_price":5.18,"underlying":"Common Stock","underlying_shares":96000},"source":{"system":"sec-edgar","filing":"0001103021-22-000065","document":"wf-form4_164798344795443.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1103021/000110302122000065/wf-form4_164798344795443.xml","form_type":"4"}},{"id":2321915,"issuer":{"id":128876,"kind":"organization","name":"BIODELIVERY SCIENCES INTERNATIONAL INC","symbol":"BDSI"},"owners":[{"id":40463,"kind":"person","name":"Bailey Jeffrey Allen","position":1,"cik":"0001500210","reported_name":"Bailey Jeffrey Allen","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Restricted Stock Units","published_at":"2022-03-22T17:11:07.000Z","date":"2022-03-22","kind":"disposition_to_issuer","acquired":false,"shares":316919,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit (\"RSU\") represents the contingent right to receive one Share."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Each Issuer RSUs that was outstanding immediately prior to the Effective Time, was cancelled and converted into the right to receive for each Share underlying such RSU, without interest and subject to deduction for any required withholding taxes, an amount in cash equal to the Merger Consideration."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Each Issuer RSUs that was outstanding immediately prior to the Effective Time, was cancelled and converted into the right to receive for each Share underlying such RSU, without interest and subject to deduction for any required withholding taxes, an amount in cash equal to the Merger Consideration."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Each Issuer RSUs that was outstanding immediately prior to the Effective Time, was cancelled and converted into the right to receive for each Share underlying such RSU, without interest and subject to deduction for any required withholding taxes, an amount in cash equal to the Merger Consideration."}],"balance_after":0,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":316919},"source":{"system":"sec-edgar","filing":"0001103021-22-000065","document":"wf-form4_164798344795443.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1103021/000110302122000065/wf-form4_164798344795443.xml","form_type":"4"}},{"id":2321914,"issuer":{"id":128876,"kind":"organization","name":"BIODELIVERY SCIENCES INTERNATIONAL INC","symbol":"BDSI"},"owners":[{"id":40463,"kind":"person","name":"Bailey Jeffrey Allen","position":1,"cik":"0001500210","reported_name":"Bailey Jeffrey Allen","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2022-03-22T17:11:07.000Z","date":"2022-03-22","kind":"other","acquired":false,"shares":105133,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This Form 4 reports securities disposed of pursuant to the terms of the Agreement and Plan of Merger (the \"Merger Agreement\"), dated as of February 14, 2022, by and among the Issuer, Collegium Pharmaceutical, Inc., (\"Parent\"), and Bristol Acquisition Company Inc., a wholly owned subsidiary of Parent (\"Merger Sub\"), pursuant to which Merger Sub completed a tender offer for shares of common stock of Issuer, $0.001 par value per share (each, a \"Share\") and thereafter merged with and into the Issuer (the \"Merger\") effective as of March 22, 2022 (the \"Effective Time\"). At the Effective Time, each issued and outstanding Share was cancelled and converted into the right to receive $5.60 in cash (the \"Merger Consideration\") without interest and subject to applicable withholding taxes."},{"field":"shares","element":"transactionShares","label":"F1","text":"This Form 4 reports securities disposed of pursuant to the terms of the Agreement and Plan of Merger (the \"Merger Agreement\"), dated as of February 14, 2022, by and among the Issuer, Collegium Pharmaceutical, Inc., (\"Parent\"), and Bristol Acquisition Company Inc., a wholly owned subsidiary of Parent (\"Merger Sub\"), pursuant to which Merger Sub completed a tender offer for shares of common stock of Issuer, $0.001 par value per share (each, a \"Share\") and thereafter merged with and into the Issuer (the \"Merger\") effective as of March 22, 2022 (the \"Effective Time\"). At the Effective Time, each issued and outstanding Share was cancelled and converted into the right to receive $5.60 in cash (the \"Merger Consideration\") without interest and subject to applicable withholding taxes."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"This Form 4 reports securities disposed of pursuant to the terms of the Agreement and Plan of Merger (the \"Merger Agreement\"), dated as of February 14, 2022, by and among the Issuer, Collegium Pharmaceutical, Inc., (\"Parent\"), and Bristol Acquisition Company Inc., a wholly owned subsidiary of Parent (\"Merger Sub\"), pursuant to which Merger Sub completed a tender offer for shares of common stock of Issuer, $0.001 par value per share (each, a \"Share\") and thereafter merged with and into the Issuer (the \"Merger\") effective as of March 22, 2022 (the \"Effective Time\"). At the Effective Time, each issued and outstanding Share was cancelled and converted into the right to receive $5.60 in cash (the \"Merger Consideration\") without interest and subject to applicable withholding taxes."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001103021-22-000065","document":"wf-form4_164798344795443.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1103021/000110302122000065/wf-form4_164798344795443.xml","form_type":"4"}},{"id":2338013,"issuer":{"id":128876,"kind":"organization","name":"BIODELIVERY SCIENCES INTERNATIONAL INC","symbol":"BDSI"},"owners":[{"id":40463,"kind":"person","name":"Bailey Jeffrey Allen","position":1,"cik":"0001500210","reported_name":"Bailey Jeffrey Allen","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Restricted Stock Units","published_at":"2022-03-11T08:08:52.000Z","date":"2022-03-09","kind":"exercise","acquired":false,"shares":5333,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares of common stock were acquired by the Reporting Person as a result of the vesting of 5,333 of RSUs granted to the Reporting Person on March 9, 2020 under the Issuer's 2019 Stock Option Incentive Plan. The remainder of the RSUs under this grant will vest on March 9, 2023."}],"balance_after":5334,"derivative":{"exercise_price":0,"expiration_date":"2023-03-08","underlying":"Common Stock","underlying_shares":5333},"source":{"system":"sec-edgar","filing":"0001103021-22-000053","document":"wf-form4_164700411850804.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1103021/000110302122000053/wf-form4_164700411850804.xml","form_type":"4"}},{"id":2338012,"issuer":{"id":128876,"kind":"organization","name":"BIODELIVERY SCIENCES INTERNATIONAL INC","symbol":"BDSI"},"owners":[{"id":40463,"kind":"person","name":"Bailey Jeffrey Allen","position":1,"cik":"0001500210","reported_name":"Bailey Jeffrey Allen","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2022-03-11T08:08:52.000Z","date":"2022-03-09","kind":"exercise","acquired":true,"shares":5333,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The shares of common stock were acquired by the Reporting Person as a result of the vesting of 5,333 of RSUs granted to the Reporting Person on March 9, 2020 under the Issuer's 2019 Stock Option Incentive Plan. The remainder of the RSUs under this grant will vest on March 9, 2023."}],"balance_after":105133,"source":{"system":"sec-edgar","filing":"0001103021-22-000053","document":"wf-form4_164700411850804.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1103021/000110302122000053/wf-form4_164700411850804.xml","form_type":"4"}},{"id":2421339,"issuer":{"id":128876,"kind":"organization","name":"BIODELIVERY SCIENCES INTERNATIONAL INC","symbol":"BDSI"},"owners":[{"id":40463,"kind":"person","name":"Bailey Jeffrey Allen","position":1,"cik":"0001500210","reported_name":"Bailey Jeffrey Allen","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Restricted Stock Units","published_at":"2022-01-31T18:00:47.000Z","date":"2022-01-27","kind":"grant","acquired":true,"shares":204918,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"The Restricted Stock Units (\"RSUs\") were issued to the Reporting Person on January 27, 2022, pursuant to a grant under the Plan. The award is subject to time-based vesting and will vest in equal portions on: (i) January 27, 2023; (ii) January 27, 2024; and (iii) January 27, 2025."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Upon vesting, each RSU entitles the Reporting Person to one share of the Issuer's common stock."}],"balance_after":204918,"derivative":{"exercise_price":0,"expiration_date":"2025-01-27","underlying":"Common Stock","underlying_shares":204918},"source":{"system":"sec-edgar","filing":"0001103021-22-000020","document":"wf-form4_164367002807246.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1103021/000110302122000020/wf-form4_164367002807246.xml","form_type":"4"}},{"id":2421338,"issuer":{"id":128876,"kind":"organization","name":"BIODELIVERY SCIENCES INTERNATIONAL INC","symbol":"BDSI"},"owners":[{"id":40463,"kind":"person","name":"Bailey Jeffrey Allen","position":1,"cik":"0001500210","reported_name":"Bailey Jeffrey Allen","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Options (right to buy)","published_at":"2022-01-31T18:00:47.000Z","date":"2022-01-27","kind":"grant","acquired":true,"shares":1143467,"price":3.66,"value":4185089.22,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"The exercise price of the stock options issued to the Reporting Person is equal to the closing price of the Issuer's common stock on January 27, 2022."},{"field":"kind","element":"transactionCoding","label":"F2","text":"The stock options were issued to the Reporting Person on January 27, 2022, pursuant to a grant under the Issuer's 2019 Stock Option Incentive Plan (the \"Plan\"). The award is subject to time-based vesting and will vest in equal portions on: (i) January 27, 2023; (ii) January 27, 2024; and (iii) January 27, 2025."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The stock options were issued to the Reporting Person on January 27, 2022, pursuant to a grant under the Issuer's 2019 Stock Option Incentive Plan (the \"Plan\"). The award is subject to time-based vesting and will vest in equal portions on: (i) January 27, 2023; (ii) January 27, 2024; and (iii) January 27, 2025."}],"balance_after":1143467,"derivative":{"exercise_price":3.66,"expiration_date":"2032-01-26","underlying":"Common Stock","underlying_shares":1143467},"source":{"system":"sec-edgar","filing":"0001103021-22-000020","document":"wf-form4_164367002807246.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1103021/000110302122000020/wf-form4_164367002807246.xml","form_type":"4"}},{"id":2521731,"issuer":{"id":128876,"kind":"organization","name":"BIODELIVERY SCIENCES INTERNATIONAL INC","symbol":"BDSI"},"owners":[{"id":40463,"kind":"person","name":"Bailey Jeffrey Allen","position":1,"cik":"0001500210","reported_name":"Bailey Jeffrey Allen","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Restricted Stock Units","published_at":"2021-11-08T16:40:42.000Z","date":"2021-11-04","kind":"exercise","acquired":false,"shares":53333,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares of common stock were acquired by the Reporting Person as a result of the vesting of Restricted Stock Units (\"RSUs\") granted to the Reporting Person on November 4, 2020, under the Issuer's 2019 Stock Option Incentive Plan. The remaining RSUs vest equally on November 4, 2022 and November 4, 2023."}],"balance_after":106667,"derivative":{"exercise_price":0,"expiration_date":"2023-11-04","underlying":"Common Stock","underlying_shares":53333},"source":{"system":"sec-edgar","filing":"0001628280-21-022261","document":"wf-form4_163640762663267.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1103021/000162828021022261/wf-form4_163640762663267.xml","form_type":"4"}},{"id":2521730,"issuer":{"id":128876,"kind":"organization","name":"BIODELIVERY SCIENCES INTERNATIONAL INC","symbol":"BDSI"},"owners":[{"id":40463,"kind":"person","name":"Bailey Jeffrey Allen","position":1,"cik":"0001500210","reported_name":"Bailey Jeffrey Allen","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2021-11-08T16:40:42.000Z","date":"2021-11-04","kind":"exercise","acquired":true,"shares":53333,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The shares of common stock were acquired by the Reporting Person as a result of the vesting of Restricted Stock Units (\"RSUs\") granted to the Reporting Person on November 4, 2020, under the Issuer's 2019 Stock Option Incentive Plan. The remaining RSUs vest equally on November 4, 2022 and November 4, 2023."}],"balance_after":99800,"source":{"system":"sec-edgar","filing":"0001628280-21-022261","document":"wf-form4_163640762663267.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1103021/000162828021022261/wf-form4_163640762663267.xml","form_type":"4"}},{"id":2608824,"issuer":{"id":128876,"kind":"organization","name":"BIODELIVERY SCIENCES INTERNATIONAL INC","symbol":"BDSI"},"owners":[{"id":40463,"kind":"person","name":"Bailey Jeffrey Allen","position":1,"cik":"0001500210","reported_name":"Bailey Jeffrey Allen","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Restricted Stock Units","published_at":"2021-08-10T18:23:10.000Z","date":"2021-08-06","kind":"exercise","acquired":false,"shares":5567,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares of common stock were acquired by the Reporting Person as a result of the vesting of Restricted Stock Units granted to the Reporting Person on July 30, 2020 under the Issuer's 2019 Stock Option Incentive Plan."}],"balance_after":0,"derivative":{"exercise_price":0,"expiration_date":"2021-08-06","underlying":"Common Stock","underlying_shares":5567},"source":{"system":"sec-edgar","filing":"0001103021-21-000076","document":"wf-form4_162863417092823.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1103021/000110302121000076/wf-form4_162863417092823.xml","form_type":"4"}},{"id":2608823,"issuer":{"id":128876,"kind":"organization","name":"BIODELIVERY SCIENCES INTERNATIONAL INC","symbol":"BDSI"},"owners":[{"id":40463,"kind":"person","name":"Bailey Jeffrey Allen","position":1,"cik":"0001500210","reported_name":"Bailey Jeffrey Allen","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2021-08-10T18:23:10.000Z","date":"2021-08-06","kind":"exercise","acquired":true,"shares":5567,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":46467,"source":{"system":"sec-edgar","filing":"0001103021-21-000076","document":"wf-form4_162863417092823.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1103021/000110302121000076/wf-form4_162863417092823.xml","form_type":"4"}},{"id":2663745,"issuer":{"id":7071,"kind":"organization","name":"Rein Therapeutics, Inc."},"owners":[{"id":40463,"kind":"person","name":"Bailey Jeffrey Allen","position":1,"cik":"0001500210","reported_name":"Bailey Jeffrey Allen","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2021-06-17T23:58:29.000Z","date":"2021-06-15","kind":"grant","acquired":true,"shares":96000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option was granted on June 15, 2021. The shares underlying the option are scheduled to vest in full on the earlier of (i) June 15, 2022 or (ii) the date of the Issuer's 2022 Annual Meeting of Stockholders."}],"balance_after":96000,"derivative":{"exercise_price":1.29,"expiration_date":"2031-06-14","underlying":"Common Stock","underlying_shares":96000},"source":{"system":"sec-edgar","filing":"0000899243-21-024533","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1500210/000089924321024533/doc4.xml","form_type":"4"}},{"id":2752925,"issuer":{"id":5390,"kind":"organization","name":"abrdn World Healthcare Fund"},"owners":[{"id":40463,"kind":"person","name":"Bailey Jeffrey Allen","position":1,"cik":"0001500210","reported_name":"Bailey Jeffrey Allen","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Subscription Rights","published_at":"2021-04-08T20:29:34.000Z","date":"2021-04-06","kind":"other","acquired":false,"shares":735,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":0,"derivative":{"exercise_price":14.262,"exercise_date":"2021-03-16","expiration_date":"2021-04-06","underlying":"Shares of Benefitial Interest","underlying_shares":245},"source":{"system":"sec-edgar","filing":"0001104659-21-048077","document":"tm2111500-5_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1500210/000110465921048077/tm2111500-5_4seq1.xml","form_type":"4"}},{"id":2752924,"issuer":{"id":5390,"kind":"organization","name":"abrdn World Healthcare Fund"},"owners":[{"id":40463,"kind":"person","name":"Bailey Jeffrey Allen","position":1,"cik":"0001500210","reported_name":"Bailey Jeffrey Allen","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Shares of Beneficial Interest","published_at":"2021-04-08T20:29:34.000Z","date":"2021-04-06","kind":"other","acquired":true,"shares":245,"price":14.262,"value":3494.19,"ownership":{"direct":true},"balance_after":980,"source":{"system":"sec-edgar","filing":"0001104659-21-048077","document":"tm2111500-5_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1500210/000110465921048077/tm2111500-5_4seq1.xml","form_type":"4"}},{"id":2795116,"issuer":{"id":128876,"kind":"organization","name":"BIODELIVERY SCIENCES INTERNATIONAL INC","symbol":"BDSI"},"owners":[{"id":40463,"kind":"person","name":"Bailey Jeffrey Allen","position":1,"cik":"0001500210","reported_name":"Bailey Jeffrey Allen","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Restricted Stock Units","published_at":"2021-03-11T16:14:46.000Z","date":"2021-03-09","kind":"exercise","acquired":false,"shares":5333,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares of common stock were acquired by the Reporting Person as a result of the vesting of 5,333 of RSUs granted to the Reporting Person on March 9, 2020 under the Stock Option Incentive Plan. The remainder of the RSUs under this grant will vest in equal amounts on each of March 9, 2022 and March 9, 2023."}],"balance_after":10667,"derivative":{"exercise_price":0,"expiration_date":"2023-03-08","underlying":"Common Stock","underlying_shares":5333},"source":{"system":"sec-edgar","filing":"0001103021-21-000031","document":"wf-form4_161549726753284.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1103021/000110302121000031/wf-form4_161549726753284.xml","form_type":"4"}},{"id":2795115,"issuer":{"id":128876,"kind":"organization","name":"BIODELIVERY SCIENCES INTERNATIONAL INC","symbol":"BDSI"},"owners":[{"id":40463,"kind":"person","name":"Bailey Jeffrey Allen","position":1,"cik":"0001500210","reported_name":"Bailey Jeffrey Allen","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2021-03-11T16:14:46.000Z","date":"2021-03-09","kind":"exercise","acquired":true,"shares":5333,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":40900,"source":{"system":"sec-edgar","filing":"0001103021-21-000031","document":"wf-form4_161549726753284.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1103021/000110302121000031/wf-form4_161549726753284.xml","form_type":"4"}},{"id":2942986,"issuer":{"id":128876,"kind":"organization","name":"BIODELIVERY SCIENCES INTERNATIONAL INC","symbol":"BDSI"},"owners":[{"id":40463,"kind":"person","name":"Bailey Jeffrey Allen","position":1,"cik":"0001500210","reported_name":"Bailey Jeffrey Allen","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2020-12-16T16:41:30.000Z","date":"2020-12-15","kind":"sale","acquired":false,"shares":10000,"price":4.35,"value":43500.0,"ownership":{"direct":true},"balance_after":35567,"source":{"system":"sec-edgar","filing":"0001103021-20-000158","document":"wf-form4_160815487692282.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1103021/000110302120000158/wf-form4_160815487692282.xml","form_type":"4"}},{"id":2990083,"issuer":{"id":128876,"kind":"organization","name":"BIODELIVERY SCIENCES INTERNATIONAL INC","symbol":"BDSI"},"owners":[{"id":40463,"kind":"person","name":"Bailey Jeffrey Allen","position":1,"cik":"0001500210","reported_name":"Bailey Jeffrey Allen","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Restricted Stock Units","published_at":"2020-11-06T17:21:54.000Z","date":"2020-11-04","kind":"grant","acquired":true,"shares":160000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"The stock options and RSUs were issued to the Reporting Person on November 4, 2020, pursuant to a grant under the Plan and are subject to vesting in thirds on each of November 4, 2021, November 4, 2022 and November 4, 2023."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The stock options and RSUs were issued to the Reporting Person on November 4, 2020, pursuant to a grant under the Plan and are subject to vesting in thirds on each of November 4, 2021, November 4, 2022 and November 4, 2023."}],"balance_after":160000,"derivative":{"expiration_date":"2023-11-04","underlying":"Common Stock","underlying_shares":160000},"source":{"system":"sec-edgar","filing":"0001103021-20-000150","document":"wf-form4_160470129788573.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1103021/000110302120000150/wf-form4_160470129788573.xml","form_type":"4"}},{"id":2990082,"issuer":{"id":128876,"kind":"organization","name":"BIODELIVERY SCIENCES INTERNATIONAL INC","symbol":"BDSI"},"owners":[{"id":40463,"kind":"person","name":"Bailey Jeffrey Allen","position":1,"cik":"0001500210","reported_name":"Bailey Jeffrey Allen","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Options (right to buy)","published_at":"2020-11-06T17:21:54.000Z","date":"2020-11-04","kind":"grant","acquired":true,"shares":840000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"The exercise price of the stock options issued to the Reporting Person is the volume-weighted average price of the Company's common stock for the 30-day period preceding November 4, 2020."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The stock options and RSUs were issued to the Reporting Person on November 4, 2020, pursuant to a grant under the Plan and are subject to vesting in thirds on each of November 4, 2021, November 4, 2022 and November 4, 2023."}],"balance_after":840000,"derivative":{"exercise_price":3.6,"expiration_date":"2030-11-04","underlying":"Common Stock","underlying_shares":840000},"source":{"system":"sec-edgar","filing":"0001103021-20-000150","document":"wf-form4_160470129788573.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1103021/000110302120000150/wf-form4_160470129788573.xml","form_type":"4"}},{"id":2990081,"issuer":{"id":128876,"kind":"organization","name":"BIODELIVERY SCIENCES INTERNATIONAL INC","symbol":"BDSI"},"owners":[{"id":40463,"kind":"person","name":"Bailey Jeffrey Allen","position":1,"cik":"0001500210","reported_name":"Bailey Jeffrey Allen","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Restricted Stock Units","published_at":"2020-11-06T17:21:54.000Z","date":"2020-11-04","kind":"exercise","acquired":false,"shares":40000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"The Restricted Stock Units (\"RSUs\") were issued to the Reporting Person on May 10, 2020, pursuant to a grant under the Issuer's 2019 Stock Option Plan (the \"Plan\").  Pursuant to the execution of an amended offer letter, the RSUs have fully vested on November 4, 2020."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The Restricted Stock Units (\"RSUs\") were issued to the Reporting Person on May 10, 2020, pursuant to a grant under the Issuer's 2019 Stock Option Plan (the \"Plan\").  Pursuant to the execution of an amended offer letter, the RSUs have fully vested on November 4, 2020."}],"balance_after":0,"derivative":{"expiration_date":"2022-05-10","underlying":"Common Stock","underlying_shares":40000},"source":{"system":"sec-edgar","filing":"0001103021-20-000150","document":"wf-form4_160470129788573.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1103021/000110302120000150/wf-form4_160470129788573.xml","form_type":"4"}},{"id":2990080,"issuer":{"id":128876,"kind":"organization","name":"BIODELIVERY SCIENCES INTERNATIONAL INC","symbol":"BDSI"},"owners":[{"id":40463,"kind":"person","name":"Bailey Jeffrey Allen","position":1,"cik":"0001500210","reported_name":"Bailey Jeffrey Allen","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2020-11-06T17:21:54.000Z","date":"2020-11-04","kind":"exercise","acquired":true,"shares":40000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":45567,"source":{"system":"sec-edgar","filing":"0001103021-20-000150","document":"wf-form4_160470129788573.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1103021/000110302120000150/wf-form4_160470129788573.xml","form_type":"4"}},{"id":3023760,"issuer":{"id":5390,"kind":"organization","name":"abrdn World Healthcare Fund"},"owners":[{"id":40463,"kind":"person","name":"Bailey Jeffrey Allen","position":1,"cik":"0001500210","reported_name":"Bailey Jeffrey Allen","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Shares of Beneficial Interest","published_at":"2020-09-23T19:57:46.000Z","date":"2020-09-23","kind":"purchase","acquired":true,"shares":710,"price":14.18,"value":10067.8,"ownership":{"direct":true},"balance_after":710,"source":{"system":"sec-edgar","filing":"0001104659-20-107792","document":"a4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1500210/000110465920107792/a4.xml","form_type":"4"}},{"id":3023759,"issuer":{"id":5102,"kind":"organization","name":"abrdn Healthcare Opportunities Fund"},"owners":[{"id":40463,"kind":"person","name":"Bailey Jeffrey Allen","position":1,"cik":"0001500210","reported_name":"Bailey Jeffrey Allen","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Shares of Beneficial Interest","published_at":"2020-09-23T19:57:17.000Z","date":"2020-09-23","kind":"purchase","acquired":true,"shares":570,"price":17.68,"value":10077.6,"ownership":{"direct":true},"balance_after":570,"source":{"system":"sec-edgar","filing":"0001104659-20-107791","document":"a4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1500210/000110465920107791/a4.xml","form_type":"4"}},{"id":3024222,"issuer":{"id":8816,"kind":"organization","name":"abrdn Healthcare Investors","symbol":"HQH"},"owners":[{"id":40463,"kind":"person","name":"Bailey Jeffrey Allen","position":1,"cik":"0001500210","reported_name":"Bailey Jeffrey Allen","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Shares of Beneficial Interest","published_at":"2020-09-23T19:56:48.000Z","date":"2020-09-23","kind":"purchase","acquired":true,"shares":490,"price":20.39,"value":9991.1,"ownership":{"direct":true},"balance_after":490,"source":{"system":"sec-edgar","filing":"0001104659-20-107790","document":"a4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/805267/000110465920107790/a4.xml","form_type":"4"}},{"id":3024160,"issuer":{"id":8835,"kind":"organization","name":"abrdn Life Sciences Investors"},"owners":[{"id":40463,"kind":"person","name":"Bailey Jeffrey Allen","position":1,"cik":"0001500210","reported_name":"Bailey Jeffrey Allen","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Shares of Beneficial Interest","published_at":"2020-09-23T19:56:02.000Z","date":"2020-09-22","kind":"purchase","acquired":true,"shares":580,"price":17.28,"value":10022.4,"ownership":{"direct":true},"balance_after":580,"source":{"system":"sec-edgar","filing":"0001104659-20-107789","document":"a4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/884121/000110465920107789/a4.xml","form_type":"4"}},{"id":3062262,"issuer":{"id":128876,"kind":"organization","name":"BIODELIVERY SCIENCES INTERNATIONAL INC","symbol":"BDSI"},"owners":[{"id":40463,"kind":"person","name":"Bailey Jeffrey Allen","position":1,"cik":"0001500210","reported_name":"Bailey Jeffrey Allen","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Restricted Stock Units","published_at":"2020-08-11T16:53:10.000Z","date":"2020-08-07","kind":"exercise","acquired":false,"shares":5567,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The restricted stock units (\"RSUs\") were issued to the Reporting Person on July 30, 2020, as compensation for service on the Issuer's board of directors. The remaining RSUs will vest in the first open window following the Company's 2021 Annual Meeting of Stockholders."}],"balance_after":5567,"derivative":{"exercise_price":0,"expiration_date":"2021-08-06","underlying":"Common Stock","underlying_shares":5567},"source":{"system":"sec-edgar","filing":"0001103021-20-000125","document":"wf-form4_159717917539790.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1103021/000110302120000125/wf-form4_159717917539790.xml","form_type":"4"}},{"id":3062261,"issuer":{"id":128876,"kind":"organization","name":"BIODELIVERY SCIENCES INTERNATIONAL INC","symbol":"BDSI"},"owners":[{"id":40463,"kind":"person","name":"Bailey Jeffrey Allen","position":1,"cik":"0001500210","reported_name":"Bailey Jeffrey Allen","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2020-08-11T16:53:10.000Z","date":"2020-08-07","kind":"exercise","acquired":true,"shares":5567,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":5567,"source":{"system":"sec-edgar","filing":"0001103021-20-000125","document":"wf-form4_159717917539790.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1103021/000110302120000125/wf-form4_159717917539790.xml","form_type":"4"}},{"id":3071559,"issuer":{"id":128876,"kind":"organization","name":"BIODELIVERY SCIENCES INTERNATIONAL INC","symbol":"BDSI"},"owners":[{"id":40463,"kind":"person","name":"Bailey Jeffrey Allen","position":1,"cik":"0001500210","reported_name":"Bailey Jeffrey Allen","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Restricted Stock Units","published_at":"2020-08-03T17:47:50.000Z","date":"2020-07-30","kind":"grant","acquired":true,"shares":11134,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The restricted stock units (\"RSUs\") were issued to the Reporting Person on July 30, 2020, pursuant to a grant under the Company's 2019 Stock Option Incentive Plan. The awards are subject to time-based vesting and will vest as follows: (i) 5,567 RSUs vest in the first open window following the filing of the Company's Quarterly Report on Form 10-Q for the quarter ended June 30, 2020, and (ii) 5,567 RSUs vest in the first open window following the Company's 2021 Annual Meeting of Stockholders."}],"balance_after":11134,"derivative":{"exercise_price":0,"expiration_date":"2021-08-06","underlying":"Common Stock","underlying_shares":11134},"source":{"system":"sec-edgar","filing":"0001103021-20-000110","document":"wf-form4_159649124172777.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1103021/000110302120000110/wf-form4_159649124172777.xml","form_type":"4"}},{"id":3071558,"issuer":{"id":128876,"kind":"organization","name":"BIODELIVERY SCIENCES INTERNATIONAL INC","symbol":"BDSI"},"owners":[{"id":40463,"kind":"person","name":"Bailey Jeffrey Allen","position":1,"cik":"0001500210","reported_name":"Bailey Jeffrey Allen","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Options (right to buy)","published_at":"2020-08-03T17:47:50.000Z","date":"2020-07-30","kind":"grant","acquired":true,"shares":66805,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock options (\"options\") were issued to the Reporting Person on July 30, 2020, pursuant to a grant under the Company's 2019 Stock Option Incentive Plan. The awards are subject to time-based vesting and will vest as follows: (i) 33,403 options vest in the first open window following the filing of the Company's Quarterly Report on Form 10-Q for the quarter ended June 30, 2020, and (ii) 33,402 options vest in the first open window following the Company's 2021 Annual Meeting of Stockholders."}],"balance_after":66805,"derivative":{"exercise_price":4.36,"expiration_date":"2030-07-29","underlying":"Common Stock","underlying_shares":66805},"source":{"system":"sec-edgar","filing":"0001103021-20-000110","document":"wf-form4_159649124172777.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1103021/000110302120000110/wf-form4_159649124172777.xml","form_type":"4"}},{"id":3105453,"issuer":{"id":7071,"kind":"organization","name":"Rein Therapeutics, Inc."},"owners":[{"id":40463,"kind":"person","name":"Bailey Jeffrey Allen","position":1,"cik":"0001500210","reported_name":"Bailey Jeffrey Allen","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2020-06-18T20:30:37.000Z","date":"2020-06-17","kind":"grant","acquired":true,"shares":12500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option was granted on June 17, 2020. The shares underlying the option are scheduled to vest in full on the earlier of (i) June 17, 2021 or (ii) the date of the Issuer's 2021 Annual Meeting of Stockholders."}],"balance_after":12500,"derivative":{"exercise_price":1.15,"expiration_date":"2030-06-16","underlying":"Common Stock","underlying_shares":12500},"source":{"system":"sec-edgar","filing":"0000899243-20-017080","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1500210/000089924320017080/doc4.xml","form_type":"4"}},{"id":3153064,"issuer":{"id":128876,"kind":"organization","name":"BIODELIVERY SCIENCES INTERNATIONAL INC","symbol":"BDSI"},"owners":[{"id":40463,"kind":"person","name":"Bailey Jeffrey Allen","position":1,"cik":"0001500210","reported_name":"Bailey Jeffrey Allen","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Restricted Stock Units","published_at":"2020-05-12T19:37:18.000Z","date":"2020-05-10","kind":"grant","acquired":true,"shares":40000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"The Restricted Stock Units (\"RSUs\") were issued to the Reporting Person on May 10, 2020, pursuant to a grant under the Plan. The award is subject to time-based vesting and will vest in equal portions on: (i) May 10, 2021; and (ii) May 10, 2022."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The Restricted Stock Units (\"RSUs\") were issued to the Reporting Person on May 10, 2020, pursuant to a grant under the Plan. The award is subject to time-based vesting and will vest in equal portions on: (i) May 10, 2021; and (ii) May 10, 2022."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The Restricted Stock Units (\"RSUs\") were issued to the Reporting Person on May 10, 2020, pursuant to a grant under the Plan. The award is subject to time-based vesting and will vest in equal portions on: (i) May 10, 2021; and (ii) May 10, 2022."}],"balance_after":40000,"derivative":{"expiration_date":"2022-05-10","underlying":"Common Stock","underlying_shares":40000},"source":{"system":"sec-edgar","filing":"0001103021-20-000083","document":"wf-form4_158932661908925.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1103021/000110302120000083/wf-form4_158932661908925.xml","form_type":"4"}},{"id":3153063,"issuer":{"id":128876,"kind":"organization","name":"BIODELIVERY SCIENCES INTERNATIONAL INC","symbol":"BDSI"},"owners":[{"id":40463,"kind":"person","name":"Bailey Jeffrey Allen","position":1,"cik":"0001500210","reported_name":"Bailey Jeffrey Allen","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Options (right to buy)","published_at":"2020-05-12T19:37:18.000Z","date":"2020-05-10","kind":"grant","acquired":true,"shares":160000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"The exercise price of the stock options issued to the Reporting Person is the volume-weighted average price of the Company's common stock for the 30-day period preceding May 10, 2020."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The Performance-based stock options were issued to the Reporting Person on May 10, 2020, pursuant to a grant under the Issuer's 2019 Stock Option Incentive Plan, as amended (the \"Plan\") and vests as follows: i) Up to 50% of the performance-based options will vest following the Board's year-end review of the Reporting Person's performance as CEO in 2020 and ii) up to 50% of the performance-based options will vest subject to the Board's determination of the Reporting Person's satisfactory performance during such CEO's first six months."}],"balance_after":160000,"derivative":{"exercise_price":4.23,"expiration_date":"2030-05-09","underlying":"Common Stock","underlying_shares":160000},"source":{"system":"sec-edgar","filing":"0001103021-20-000083","document":"wf-form4_158932661908925.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1103021/000110302120000083/wf-form4_158932661908925.xml","form_type":"4"}},{"id":3205980,"issuer":{"id":128876,"kind":"organization","name":"BIODELIVERY SCIENCES INTERNATIONAL INC","symbol":"BDSI"},"owners":[{"id":40463,"kind":"person","name":"Bailey Jeffrey Allen","position":1,"cik":"0001500210","reported_name":"Bailey Jeffrey Allen","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2020-03-17T16:26:02.000Z","date":"2020-03-09","kind":"grant","acquired":true,"shares":16000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock options and restricted stock were issued to the Reporting Person on March 9, 2020, pursuant to a grant under the Issuer's 2019 Stock Option Incentive Plan (the \"Plan\"). The award is subject to time-based vesting and will vest in equal portions on: (i) March 9, 2021; (ii) March 9, 2022; and (iii) March 9, 2023."}],"balance_after":16000,"derivative":{"exercise_price":0,"expiration_date":"2023-03-08","underlying":"Common Stock","underlying_shares":16000},"source":{"system":"sec-edgar","filing":"0001103021-20-000046","document":"wf-form4_158447674471808.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1103021/000110302120000046/wf-form4_158447674471808.xml","form_type":"4"}},{"id":3205979,"issuer":{"id":128876,"kind":"organization","name":"BIODELIVERY SCIENCES INTERNATIONAL INC","symbol":"BDSI"},"owners":[{"id":40463,"kind":"person","name":"Bailey Jeffrey Allen","position":1,"cik":"0001500210","reported_name":"Bailey Jeffrey Allen","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options (right to buy)","published_at":"2020-03-17T16:26:02.000Z","date":"2020-03-09","kind":"grant","acquired":true,"shares":96000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock options and restricted stock were issued to the Reporting Person on March 9, 2020, pursuant to a grant under the Issuer's 2019 Stock Option Incentive Plan (the \"Plan\"). The award is subject to time-based vesting and will vest in equal portions on: (i) March 9, 2021; (ii) March 9, 2022; and (iii) March 9, 2023."}],"balance_after":96000,"derivative":{"exercise_price":5.18,"expiration_date":"2030-03-08","underlying":"Common Stock","underlying_shares":96000},"source":{"system":"sec-edgar","filing":"0001103021-20-000046","document":"wf-form4_158447674471808.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1103021/000110302120000046/wf-form4_158447674471808.xml","form_type":"4"}},{"id":3368282,"issuer":{"id":7071,"kind":"organization","name":"Rein Therapeutics, Inc."},"owners":[{"id":40463,"kind":"person","name":"Bailey Jeffrey Allen","position":1,"cik":"0001500210","reported_name":"Bailey Jeffrey Allen","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-11-18T21:15:56.000Z","date":"2019-11-15","kind":"purchase","acquired":true,"shares":39142,"price":0.51,"value":19962.42,"ownership":{"direct":true},"balance_after":74894,"source":{"system":"sec-edgar","filing":"0000899243-19-027510","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1500210/000089924319027510/doc4.xml","form_type":"4"}},{"id":3368281,"issuer":{"id":7071,"kind":"organization","name":"Rein Therapeutics, Inc."},"owners":[{"id":40463,"kind":"person","name":"Bailey Jeffrey Allen","position":1,"cik":"0001500210","reported_name":"Bailey Jeffrey Allen","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-11-18T21:15:56.000Z","date":"2019-11-14","kind":"purchase","acquired":true,"shares":15858,"price":0.51,"value":8087.58,"ownership":{"direct":true},"balance_after":35752,"source":{"system":"sec-edgar","filing":"0000899243-19-027510","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1500210/000089924319027510/doc4.xml","form_type":"4"}},{"id":3371297,"issuer":{"id":7071,"kind":"organization","name":"Rein Therapeutics, Inc."},"owners":[{"id":40463,"kind":"person","name":"Bailey Jeffrey Allen","position":1,"cik":"0001500210","reported_name":"Bailey Jeffrey Allen","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-11-14T21:23:25.000Z","date":"2019-11-12","kind":"purchase","acquired":true,"shares":19894,"price":0.53,"value":10543.82,"ownership":{"direct":true},"balance_after":19894,"source":{"system":"sec-edgar","filing":"0000899243-19-027279","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1500210/000089924319027279/doc4.xml","form_type":"4"}},{"id":3481414,"issuer":{"id":7071,"kind":"organization","name":"Rein Therapeutics, Inc."},"owners":[{"id":40463,"kind":"person","name":"Bailey Jeffrey Allen","position":1,"cik":"0001500210","reported_name":"Bailey Jeffrey Allen","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2019-06-21T20:05:20.000Z","date":"2019-06-19","kind":"grant","acquired":true,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option was granted on June 19, 2019. The shares underlying the option are scheduled to vest in full on the earlier of (i) June 19, 2020 or (ii) the date of the Issuer's 2020 Annual Meeting of Stockholders."}],"balance_after":50000,"derivative":{"exercise_price":0.86,"expiration_date":"2029-06-18","underlying":"Common Stock","underlying_shares":50000},"source":{"system":"sec-edgar","filing":"0000899243-19-017788","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1500210/000089924319017788/doc4.xml","form_type":"4"}},{"id":3884084,"issuer":{"id":7071,"kind":"organization","name":"Rein Therapeutics, Inc."},"owners":[{"id":40463,"kind":"person","name":"Bailey Jeffrey Allen","position":1,"cik":"0001500210","reported_name":"Bailey Jeffrey Allen","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2018-06-25T22:20:15.000Z","date":"2018-06-21","kind":"grant","acquired":true,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option was granted on June 21, 2018. The shares underlying the option are scheduled to vest in full on the earlier of (i) June 21, 2019 or (ii) the date of the Issuer's 2019 Annual Meeting of Stockholders."}],"balance_after":10000,"derivative":{"exercise_price":6.02,"expiration_date":"2028-06-20","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0000899243-18-017972","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1500210/000089924318017972/doc4.xml","form_type":"4"}},{"id":3989664,"issuer":{"id":7071,"kind":"organization","name":"Rein Therapeutics, Inc."},"owners":[{"id":40463,"kind":"person","name":"Bailey Jeffrey Allen","position":1,"cik":"0001500210","reported_name":"Bailey Jeffrey Allen","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2018-03-19T20:06:04.000Z","date":"2018-03-15","kind":"grant","acquired":true,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option was granted on March 15, 2018. The shares underlying the option are scheduled to vest in equal annual installments over three years from March 15, 2018."}],"balance_after":20000,"derivative":{"exercise_price":9.02,"expiration_date":"2028-03-14","underlying":"Common Stock","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0000899243-18-007928","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1500210/000089924318007928/doc4.xml","form_type":"4"}},{"id":4183315,"issuer":{"id":172389,"kind":"organization","name":"LANDAUER INC","symbol":"LDR"},"owners":[{"id":40463,"kind":"person","name":"Bailey Jeffrey Allen","position":1,"cik":"0001500210","reported_name":"Bailey Jeffrey Allen","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2017-10-19T18:12:35.000Z","date":"2017-10-19","kind":"disposition_to_issuer","acquired":false,"shares":8943,"price":67.25,"value":601416.75,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Pursuant to an Agreement and Plan of Merger, dated September 6, 2017 (the ?Merger Agreement?), by and among Fern Merger Sub Inc., a Delaware corporation (?Purchaser?) and an indirect wholly owned subsidiary of Fortive Corporation, a Delaware corporation, and Landauer, Inc., a Delaware corporation (the ?Issuer?), each outstanding share of the Issuer?s common stock was disposed of pursuant to the closing on October 19, 2017 of a cash tender offer by Purchaser to acquire common stock of Issuer in exchange for $67.25 per share in cash, subject to any required withholding of taxes, without interest."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Pursuant to an Agreement and Plan of Merger, dated September 6, 2017 (the ?Merger Agreement?), by and among Fern Merger Sub Inc., a Delaware corporation (?Purchaser?) and an indirect wholly owned subsidiary of Fortive Corporation, a Delaware corporation, and Landauer, Inc., a Delaware corporation (the ?Issuer?), each outstanding share of the Issuer?s common stock was disposed of pursuant to the closing on October 19, 2017 of a cash tender offer by Purchaser to acquire common stock of Issuer in exchange for $67.25 per share in cash, subject to any required withholding of taxes, without interest."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0000825410-17-000084","document":"certent-form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/825410/000082541017000084/certent-form4.xml","form_type":"4"}},{"id":4437593,"issuer":{"id":172389,"kind":"organization","name":"LANDAUER INC","symbol":"LDR"},"owners":[{"id":40463,"kind":"person","name":"Bailey Jeffrey Allen","position":1,"cik":"0001500210","reported_name":"Bailey Jeffrey Allen","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2017-02-21T18:05:07.000Z","date":"2017-02-16","kind":"grant","acquired":true,"shares":2260,"price":50.9,"value":115034.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Shares are restricted stock subject to vesting requirements."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"2,260 of shares are restricted stock subject to vesting requirements."}],"balance_after":8943,"source":{"system":"sec-edgar","filing":"0000825410-17-000014","document":"certent-form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/825410/000082541017000014/certent-form4.xml","form_type":"4"}}]}